
Mettler-Toledo International MTD
$ 1 319.11
-1.67%
Annual report 2025
added 02-06-2026
Mettler-Toledo International Long Term Debt Current 2011-2026 | MTD
Annual Long Term Debt Current Mettler-Toledo International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.1 M | 29.1 M | 28.5 M | 29.3 M | 30.6 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.1 M | 28.5 M | 30.5 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 522.71 | 0.52 % | $ 15.1 B | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 17.77 | 0.77 % | $ 947 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Natera
NTRA
|
7.64 M | $ 211.83 | -1.31 % | $ 20.8 B | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
662 K | $ 1.4 | 1.45 % | $ 1.86 M | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 29.09 | - | $ 20 B | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 24.73 | 1.46 % | $ 687 M | ||
|
Senseonics Holdings
SENS
|
496 K | $ 6.85 | 1.48 % | $ 286 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Soleno Therapeutics
SLNO
|
726 K | $ 52.6 | -0.05 % | $ 2.67 B | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 183.05 | 2.09 % | $ 9.07 B | ||
|
Neuronetics
STIM
|
5.56 M | $ 1.44 | 0.35 % | $ 95 M | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 2.2 | - | $ 9.73 M | ||
|
Danaher Corporation
DHR
|
199 M | $ 198.66 | 0.02 % | $ 142 B | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
79 M | $ 131.2 | 0.68 % | $ 20.9 B | ||
|
Thermo Fisher Scientific
TMO
|
275 M | $ 527.7 | 0.09 % | $ 199 B | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.62 | 3.23 % | $ 1.1 B | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 16.18 | 1.0 % | $ 489 M | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 56.72 | -1.2 % | $ 3.39 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Guardant Health
GH
|
27.7 M | $ 85.26 | -1.32 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 5.27 | 7.23 % | $ 488 M | ||
|
Anixa Biosciences
ANIX
|
41 K | $ 2.88 | - | $ 93.5 K | ||
|
Biomerica
BMRA
|
358 K | $ 2.11 | 0.48 % | $ 4.85 M | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 114.25 | 1.05 % | $ 9.42 B | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 268.6 | -0.1 % | $ 22.3 B | ||
|
Celcuity
CELC
|
54 K | $ 120.17 | -0.56 % | $ 5.62 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.53 | -0.83 % | $ 2.07 B | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 83.04 | 0.36 % | $ 5.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 192.47 | -0.87 % | $ 21.4 B |